Can a tailored web portal help pancreatic cancer patients exercise and eat better during chemotherapy?
NCT ID NCT07651358
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a web-based program called COMPASS that provides personalized exercise and nutrition advice, along with text messages, activity trackers, and coaching, for people with stage I-III pancreatic cancer receiving chemotherapy before surgery. The goal is to see if the program is practical and helpful for improving physical activity and diet during a challenging treatment period. The study enrolls 30 participants and measures how many join, stick with it, and follow the recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Web-based lifestyle program with tailored nutrition and physical activity recommendations, text messages, electronic trackers, and coaching
- What this could lead to
- If successful, this program could offer a practical way to help pancreatic cancer patients stay active and eat well during tough treatment, potentially improving their well-being.
- What could go wrong
- This is a small, early feasibility study with only 30 participants, so results may not apply to everyone. The program may not lead to lasting behavior changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I PANCREATIC CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OHSU Knight Cancer Institute
RECRUITINGPortland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Decades-Old parasite drug help fight pancreatic cancer?
- New drug combo aims to shrink Hard-to-Treat pancreatic and ovarian tumors
- New drug AB801 aims to boost chemo and immunotherapy in tough cancers
- New drug cocktail targets tough pancreatic tumors
- New PET tracer could light up pancreatic tumors
- New drug combo shows promise for tough cancers